Am. J. Respir. Crit. Care Med., Volume 162, Number 2, August 2000, 534-538

Muscarinic Control of Histamine Release from Airways
Inhibitory M1-receptors in Human Bronchi but Absence in Rat Trachea

TORSTEN REINHEIMER, THORSTEN MÖHLIG, SACHA ZIMMERMANN, KARL-DIETER HÖHLE, and IGNAZ WESSLER

Department of Pharmacology, University of Mainz and Academic St. Hildegardis Hospital, Mainz, Germany

Isolated human bronchi and rat tracheae were incubated in organ baths to measure histamine release. The calcium ionophore A23187, 3 µmol/L in rat trachea and 10 µmol/L in human bronchi, stimulated histamine release by 145 ± 50% (n = 6) and 270 ± 48% (n = 7) above the prestimulation level, respectively. Acetylcholine (100 pmol/L; human bronchi) or oxotremorine (1, 100, 10,000 nmol/L; rat trachea) did not affect the spontaneous histamine release. In rat tracheae neither acetylcholine nor oxotremorine inhibited A23187-evoked histamine release, whereas 100 pmol/L acetylcholine significantly suppressed the evoked histamine release in human bronchi by 86%. For receptor characterization the following subtype-specific muscarinic receptor antagonists were applied: pirenzepine (M1 subtype), para-fluorohexahydrosiladifendiol (pFHHSiD; similar affinities at human cloned M1-, M3-, and M4-receptors), AF-DX 116 (M2 subtype), and clozapine (antagonist at cloned M1-, M2-, M3-receptors; agonist at cloned M4-receptors). Pirenzepine, pFHHSiD, AF-DX 116, and clozapine (100 nmol/L each) antagonized the inhibitory effect of 100 pmol/L acetylcholine by 83 ± 20% (n = 6), 83 ± 9% (n = 8), 50 ± 14% (n = 6), and 35 ± 7% (). In conclusion, a species difference exists in the cholinergic control of histamine release between human and rat airways. In human airways muscarinic receptors most likely of the M1 subtype are involved in the inhibitory control of mast cell function, whereas such an inhibitory pathway does not exist in the rat trachea.

This article has been cited by other articles:

				Y. Maeda, N. Hizawa, E. Jinushi, A. Honda, D. Takahashi, Y. Fukui, S. Konno, T. Shimizu, H. Shimizu, E. Yamaguchi, et al. Polymorphisms in the Muscarinic Receptor 1 Gene Confer Susceptibility to Asthma in Japanese Subjects Am. J. Respir. Crit. Care Med., November 15, 2006; 174(10): 1119 - 1124. [Abstract] [Full Text] [PDF]

				L. Motterle, Y. Diebold, A. Enriquez de Salamanca, V. Saez, C. Garcia-Vazquez, M. E. Stern, M. Calonge, and A. Leonardi Altered expression of neurotransmitter receptors and neuromediators in vernal keratoconjunctivitis. Arch Ophthalmol, April 1, 2006; 124(4): 462 - 468. [Abstract] [Full Text] [PDF]

				J. Belik, J. Pan, R. P. Jankov, and A. K. Tanswell Bronchial epithelium-associated pulmonary arterial muscle relaxation in the rat is absent in the fetus and suppressed by postnatal hypoxia Am J Physiol Lung Cell Mol Physiol, February 1, 2005; 288(2): L384 - L389. [Abstract] [Full Text] [PDF]

				N. Struckmann, S. Schwering, S. Wiegand, A. Gschnell, M. Yamada, W. Kummer, J. Wess, and R. V. Haberberger Role of Muscarinic Receptor Subtypes in the Constriction of Peripheral Airways: Studies on Receptor-Deficient Mice Mol. Pharmacol., December 1, 2003; 64(6): 1444 - 1451. [Abstract] [Full Text] [PDF]

				M. J. TOBIN Asthma, Airway Biology, and Allergic Rhinitis in AJRCCM 2000 Am. J. Respir. Crit. Care Med., November 1, 2001; 164(9): 1559 - 1580. [Full Text] [PDF]